FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are…#fda #novonordisk #wegovy #johnsharretts #marthagulati #ozempic #medicare #tricianeuman #kff #ahip (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
FDA clears Wegovy manufacturer to market weight-loss drug for heart health
The Food and Drug Administration on Friday approved Wegovy manufacturer Novo Nordisk ' s application to add cardiovascular benefits to the weight-loss drug ' s label. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 8, 2024 Category: Consumer Health News Source Type: news
Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients
The popular weight-loss drug Wegovy can now be used to reduce the risk of stroke, heart attacks and other serious heart problems in patients who are overweight or who have obesity (Source: ABC News: Health)
Source: ABC News: Health - March 8, 2024 Category: Consumer Health News Tags: Health Source Type: news
Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.
The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
[time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
FDA approves Wegovy weight-loss shot for heart disease patients - including those who are not obese
The FDA approved the medication for this use in non-diabetic patients who had heart disease today, following clinical trials showing it slashed the risk of the complications by up to 28 percent. (Source: the Mail online | Health)
Source: the Mail online | Health - March 8, 2024 Category: Consumer Health News Source Type: news
FDA Approves Wegovy to Help Prevent Heart Attack, Stroke
FRIDAY, March 8, 2024 -- Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death.“Wegovy is now... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 8, 2024 Category: General Medicine Source Type: news
Options Medical Weight Loss Announces Tips to Commemorate Obesity Care Week
Premier medical weight loss clinic offers the chance to win a complimentary* program. COLUMBUS, Ohio, March 8, 2024 /PRNewswire-PRWeb/ -- Options Medical Weight Loss is honoring Obesity Care Week throughout the month of March with education and weight loss program giveaways. As part of... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 8, 2024 Category: Pharmaceuticals Source Type: news
Ozempic maker's new weight loss pill that is TWICE as good as blockbuster skinny jab won't be available in Britain and the US until 2026
Novo Nordisk yesterday unveiled promising early results for its experimental drug amycretin that showed patients could lose more than 13% of their weight after just 12 weeks. (Source: the Mail online | Health)
Source: the Mail online | Health - March 8, 2024 Category: Consumer Health News Source Type: news
Oprah Winfrey is returning to broadcast TV to shed light on a controversial industry
Oprah Winfrey appears to be making good on her promise to continue the conversation about weight loss, despite stepping down from WeightWatchers’ board of directors last week. The billionaire has announced that she is releasing a TV special with ABC on March 18 called “An Oprah Special: Shame,…#oprahwinfrey #weightwatchers #abc #ww #peoplemagazine #glp1 #ozempicwegovyetc #novonordisk #nvo #novonordisks (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2024 Category: Consumer Health News Source Type: news
Novo Nordisk chief seeks more deals to cement weight-loss lead amid ‘hype’
Drugmaker releases promising trial results for a pill and expects to enter China this year (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 8, 2024 Category: Pharmaceuticals Source Type: news
Novo Nordisk expects China to approve weight loss drug Wegovy this year
(Source: Reuters: Health)
Source: Reuters: Health - March 8, 2024 Category: Consumer Health News Source Type: news
Eli Lilly - maker of blockbuster weight loss drugs - urges stars to stop using them for 'vanity' reasons if they're not obese
In a bizarre 30-second advert on television, Eli Lilly - which makes weight loss drugs Mounjaro and Zepbound - urged those only looking to lose a few pounds to steer clear of the weight loss drugs. (Source: the Mail online | Health)
Source: the Mail online | Health - March 7, 2024 Category: Consumer Health News Source Type: news
Ozempic maker unveils new weight loss pill TWICE as good as its blockbuster jab - sending company's value rocketing above Tesla's
Novo Nordisk has revealed preliminary study results showing that its weight loss pill performed better than blockbuster shots. The company is now more valuable than Tesla and Visa at $566 billion. (Source: the Mail online | Health)
Source: the Mail online | Health - March 7, 2024 Category: Consumer Health News Source Type: news
Ozempic Maker ’s New Weight Loss Pill Beats Wegovy In Early Trial — What To Know About Novo Nordisk’s Amycretin
Patients taking the drug in an early stage clinical trial lost 13% of their weight over 12 weeks, Novo Nordisk told investors. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 7, 2024 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news
TikTok Influencers Are Now Treating Ozempic Side Effects
Every day dozens of people come to Jennifer Witherspoon—a former dental office manager with zero medical training—for help managing nausea, headaches, and other side effects that can come with taking weight-loss shots. She even crafted a template response to help her quickly get through the messages.
“People have offered to pay me, begged me to start a podcast, asked me to call their sisters-in-law, wanted me to call their doctor,” she said. “One lady even invited me to her wedding.” Even Oprah’s production company reached out to feature one of her videos in a prime time specia...
Source: TIME: Health - March 7, 2024 Category: Consumer Health News Authors: Madison Muller, Andre Tartar, and Tanaz Meghjani/Bloomberg Tags: Uncategorized healthscienceclimate wire Source Type: news
